Results 231 to 240 of about 1,772,223 (306)
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Dosage and Administration-Related Emotional and Clinical Outcomes of Buprenorphine Treatment for Opioid Use Disorder: A Systematic Review and Meta-Analysis. [PDF]
Xiao Y, Ramos MR, Montgomery-Marks P.
europepmc +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Glucocorticoids: an enemy or a friend for the dermatologist? recommendations for proper use and safe discontinuation. [PDF]
Sali E +8 more
europepmc +1 more source
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies. [PDF]
Raman S +3 more
europepmc +1 more source
A Comparison of Long-Acting Progesterone and Intravaginal Device Priming Protocols for Inducing Ovarian Activity in Dromedary Camels. [PDF]
Moussa M, Ahmed S, Elbaz M, Pasha K.
europepmc +1 more source
Hydrogel-Based Depot Systems in Psychiatric Pharmacotherapy: A Narrative Review Rethinking Long-Acting Drug Delivery. [PDF]
Predoi ED +9 more
europepmc +1 more source

